While investigating the molecular mechanism of BC recurrence and distant metastasis after chemotherapy, researchers found that HOXC10 was responsible for suppressing apoptosis and inducing the NF-κB pathway in the BC cells treated with doxorubicin, paclitaxel, or carboplatin. Here, HOXC10 is linked to breast cancer.